Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were needed to confirm the benefit. | Video
Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a U.S. study testing it in the most critically ill COVID-19 patients.
* Early positive results for Pfizer, BioNTech vaccine
Nearly 300 cases of a rare, life-threatening syndrome in children and adolescents associated with the novel coronavirus have been identified in the United States in two studies in The New England Journal of Medicine.
Sexual activity among young American men has declined sharply since 2000, with nearly a third reporting no sex with a partner in the prior year, according to a survey study published on Friday that suggests social media and electronic gaming might be filling the void.
The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed. | Video
U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.